Pharmaceuticals

BUTYLATED HYDROXYANISOLE CDMF

Excipient developed for pharmaceutical applications. It acts as an antioxidant.

BUTYLATED HYDROXYANISOLE EXCIPIENT GRADE

Excipient for pharmaceutical applications such as solid and semi-solid dosage forms.Benefits:DMF filed excipient - CDE # F20200000188All peak positions are within 5cm-1cm of those determined for 3-tert-Butyl-4-hydroxyanisole standard

BUTYLATED HYDROXYANISOLE PH.EUR

Excipient for use in pharmaceutical applications. It acts as an antioxidant.

BUTYLATED HYDROXYANISOLE USP-NF

Excipient for use in pharmaceutical applications.

BUTYLATED HYDROXYANISOLE USP-NF/PH.EUR

Excipient for pharmaceutical applications such as solid and semi-solid dosage forms.Benefits:DMF filed excipient - CDE # F20200000188All peak positions are within 5cm-1cm of those determined for 3-tert-Butyl-4-hydroxyanisole standard

BUTYLATED HYDROXYANISOLE USP/PH. EUR

Excipient for pharmaceutical applications such as solid and semi-solid dosage forms.Benefits:DMF filed excipient - CDE # F20200000188All peak positions are within 5cm-1cm of those determined for 3-tert-Butyl-4-hydroxyanisole standard

BUTYLATED HYDROXYTOLUENE

Excipient specially developed for solid and semi-solid dosage forms. It is an antioxidant and reducing agent used in injectable formulations.Benefits:Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)DMF Filed - CDE # F20200000189

BUTYLATED HYDROXYTOLUENE CDMF

Excipient designed for pharmaceutical applications.